Browse

You are looking at 451 - 500 of 1,337 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Methylcellulose Suspension 10 mg/mL (1%)

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Methyldopa Syrup 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metolazone Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metoprolol Tartrate Suspension 10 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metoprolol Tartrate Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metronidazole Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metronidazole Suspension 50 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metronidazole Syrup 5 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Metronidazole Syrup 5 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Mexiletine Solution 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Midazolam Hydrochloride Gelatin 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Midazolam Hydrochloride Gelatin 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Midazolam Hydrochloride Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Midazolam Hydrochloride Syrup 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Minocycline Hydrochloride Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Minoxidil Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Morphine Hydrochloride Solution 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Morphine Sulfate Solution 0.4 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Moxifloxacin Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Mycophenolate Mofetil Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Mycophenolate Mofetil Syrup 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Naproxen Suspension 25 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Naratriptan Hydrochloride Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nifedipine Solution 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nifedipine Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nifedipine Suspension 4 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nifedipine Suspension 4 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nitrofurantoin Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Nizatidine Solution 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Olmesartan Medoxomil Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Omeprazole Solution 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Omeprazole Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ondansetron Hydrochloride Suspension 0.8 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Ondansetron Hydrochloride Suspension 0.8 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oseltamivir Phosphate Suspension 6 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oseltamivir Phosphate Syrup 15 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oseltamivir Phosphate Syrup 6 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oxandrolone Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oxandrolone Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Oxandrolone Suspension 3 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pantoprazole Solution 2 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pantoprazole Solution 2 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Penicillamine-D Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pentoxifylline Solution 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

6 Pharmacogenetics and Molecular Testing

Jason H. Karnes and Laura B. Ramsey

Restricted access

5 PHARMACOGENOMIC IMPACTS ON PHARMACOKINETICS

Cheryl D. Cropp

Restricted access

18 PHENOBARBITAL

Kimberly B. Tallian and Douglas M. Anderson

Restricted access

CH 1.10 Phenobarbital

John E. Murphy

Restricted access

CH 2.10 Phenobarbital

John E. Murphy

Restricted access

Phenobarbital Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes